Updated on 18 June 2012
Extending its relations with multinational companies, Lupin strategically collaborated with Eli Lilly India to promote and distribute Lilly's Huminsulin range of products.
Lupin is now looking forward to expanding its manufacturing base. It is setting up a new state-of-the-art formulation manufacturing facility at the special economic zone (SEZ), Mihan in Maharashtra, India.
Lupin has 11 world class manufacturing facilities spread across India and Japan, most of which have been scrutinized by leading regulators, such as US FDA, UK MHRA, WHO, Australian TGA, and Japan's MHLW.
Get direct access to more such reports. Subscribe to BioSpectrum Bureau 
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
